Adverum Biotechnologies, Inc.
ADVM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$48 | -$49 | -$47 | -$41 |
| Dep. & Amort. | $0 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2 | $2 | $3 | $0 |
| Change in WC | $17 | $7 | $0 | $9 |
| Other Non-Cash | $0 | -$0 | $1 | $3 |
| Operating Cash Flow | -$28 | -$39 | -$43 | -$28 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$2 | $0 | -$19 |
| Inv. Sales/Matur. | $2 | $34 | $32 | $15 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $2 | $32 | $31 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $10 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $10 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$16 | -$7 | -$11 | -$32 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $44 | $51 | $63 | $93 |
| End Cash | $28 | $44 | $51 | $61 |
| Free Cash Flow | -$28 | -$39 | -$43 | -$28 |